Neurological Management of Von Hippel-Lindau Disease

@article{Hodgson2016NeurologicalMO,
  title={Neurological Management of Von Hippel-Lindau Disease},
  author={T. S. Hodgson and S. Nielsen and M. Lesniak and R. Lukas},
  journal={The Neurologist},
  year={2016},
  volume={21},
  pages={73–78}
}
  • T. S. Hodgson, S. Nielsen, +1 author R. Lukas
  • Published 2016
  • Medicine
  • The Neurologist
  • Von Hippel-Lindau disease is a genetic condition due to mutation of the Von Hippel-Lindau gene, which leads to an increased risk in the development of hemangioblastomas of the brain and spinal cord. The pathophysiology of disease and its clinical manifestations, as they pertain to the general neurologist, are discussed. Therapeutic management of central nervous system hemangioblastomas ranging from neurosurgical resection, radiation therapy, and systemic therapies is reviewed. 
    2 Citations

    Topics from this paper.

    References

    SHOWING 1-10 OF 71 REFERENCES
    von Hippel–Lindau disease: A clinical and scientific review
    • 400
    • PDF
    von Hippel-Lindau disease
    • 737
    Management of von Hippel–Lindau disease-associated CNS lesions
    • 42
    • Highly Influential
    Imaging features of von Hippel-Lindau disease.
    • 114
    Von Hippel-Lindau disease.
    • 125
    • PDF
    Von Hippel-Lindau Disease: A Genetic and Clinical Review
    • 31
    The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
    • 348
    • Highly Influential